REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Plant Material Or Plant Extract Of Undetermined Constitution As Active Ingredient (e.g., Herbal Remedy, Herbal Extract, Powder, Oil, Etc.) > Containing Or Obtained From A Flower Or Blossom (aka Flos) Containing Or Obtained From A Flower Or Blossom (aka Flos)Containing Or Obtained From A Flower Or Blossom (aka Flos) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.07/26/07 - 20070172532 - Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 A novel formulation is provided that serves to specifically inhibit the COX-2 mediated inflammatory response in animals. The formulation comprises an effective amount of component I selected from the group consisting of alpha acids and beta acids and an effective amount of at least one component II selected from the ... 07/19/07 - 20070166418 - Treatment modalities for autoimmune diseases Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed. ... 05/17/07 - 20070110835 - Method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity The present invention relates to a method for the production of a hop extract which is enriched in 8-prenylnaringenin with respect to 6-prenylnaringenin, which method comprises the steps of subjecting a hop product to (1) an isomerisation reaction in the presence of water as a solvent and in the presence ... 03/15/07 - 20070059393 - Composition for inhibition or prevention of bone density The present invention relates to a composition for the inhibition or prevention of a bone mineral density reduction, or food and drink for use in such application, comprising isoxanthohumol or an isomerized hop extract as an active ingredient. According to the present invention, a bone mineral density reduction can be ... 01/25/07 - 20070020352 - Treatment modalities for autoimmune diseases Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed. ... 01/04/07 - 20070003646 - Methods of administering anti-inflammatory cyclooxygenase-2 selective inhibitors Disclosed are novel anti-inflammatory pharmaceutical compositions and related methods that exhibit potent and selective inhibition of the cycloooxygenase-2 (COX-2) enzyme. The formulation can comprise a hops extract that exhibits COX-2 selectivity as defined by dividing the IC50 COX-2/IC50COX-1 concentrations that are determined by testing with the William Harvey Whole Blood ... 12/14/06 - 20060280822 - Extract of nelumbins semen for the treatment of depression Disclosed are a Nelumbinis Semen extract for treating depression, method of preparing the extract, and a pharmaceutical composition and a health food, comprising the extract. The Nelumbinis Semen extract is prepared by extracting Nelumbinis Semen with an alcohol or an alcohol solution. The Nelumbinis Semen extract has been demostrated using ... 12/07/06 - 20060275521 - Hibiscus anthocyanins for inhibiting cancers This invention provides a composition for inhibiting cancer cell growth comprising Hibiscus anthocyanins extracted from Hibiscus sabdariffa. This invention also provides a method for treating cancer comprising administering a patient with an effective amount of Hibiscus anthocyanins. ... 10/19/06 - 20060233902 - Compositions and foods for improving lipid metabolism It is intended to provide compositions and foods for use in the treatment, prophylaxis, or amelioration of diseases or symptoms which can be treated, prevented or ameliorated by activating PPAR, in particular, insulin resistant diabetes and hyperlipidemia. Namely, medicinal compositions usable in treating, preventing or improving diseases or symptoms which ... 08/31/06 - 20060193933 - Modulation of inflammation by hops fractions and derivatives A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. ... 08/10/06 - 20060177531 - Compositions that treat or inhibit pathological conditions associated with inflammatory response A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments ... 07/06/06 - 20060147568 - Blood pressure-lowering agent, vascular flexibility -improving agent and foods having these functions imparted thereto According to the present invention, there is provided a blood pressure-lowering agent, a vascular flexibility-ameliorating agent and foods having these functions imparted thereto, which are comprising isohumulones or a hop extract and/or an isomerized hop extract as an active ingredient. ... 06/29/06 - 20060141082 - Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity The invention provides hops (Humulis lupulus) extracts or derivatives thereof for use in treating a patient prophylactically and/or therapeutically for ulcerogenic-type disorders of the stomach and/or intestines. The ulcerogenic disorders can be of the type chemically induced, environmentally-induced, infection-induced, and/or stress-induced. The invention also provides a pharmaceutical composition comprising an ... 06/29/06 - 20060141081 - Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity The invention provides hops (Humulus lupulus) extracts or derivatives thereof for use in treating a patient prophylactically and/or therapeutically for ulcerogenic-type disorders of the stomach and/or intestines. The ulcerogenic disorders can be of the type chemically induced, environmentally-induced, infection-induced, and/or stress-induced. The invention also provides a pharmaceutical composition comprising an ... 06/22/06 - 20060134249 - Proteotoxin neutralizer Proteotoxin neutralizers containing as the active ingredient proanthocyanidins obtained from hop. ... 06/22/06 - 20060134248 - Hop acids as a replacement for antibiotics in animal feed A method of using hop acids for increasing food and energy uptake from feed by livestock is described which includes delivering the hop acids for oral ingestion to the animals by mixing the acids with livestock feed. The acids are mixed with the feed in an amount to inhibit certain ... 06/15/06 - 20060127517 - Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments ... 06/15/06 - 20060127516 - Modulation of inflammation by hops fractions and derivatives A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. ... 06/15/06 - 20060127515 - Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments ... 06/15/06 - 20060127514 - Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments ... 06/15/06 - 20060127513 - Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments ... 06/15/06 - 20060127512 - Modulation of inflammation by hops fractions and derivatives A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. ... 06/15/06 - 20060127511 - Modulation of inflammation by hops fractions and derivatives A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. ... 03/09/06 - 20060051440 - Factors that bind intestinal toxins Methods for neutralizing bacterial toxins such as Shiga toxins and cholera toxins are disclosed. In a particular embodiment, a method is provided for treating a subject suffering from an infection caused by an Stx-producing organism by administering a therapeutically effective amount of a hop bract tannin obtained from Humulus lupulus. ... 02/23/06 - 20060040005 - Anti peptic ulcer activity of an extract of a plant flower woodfordia fruticosa The present invention provides a pharmaceutical composition comprising an effective amount of an extract or lyophilized extract or at least one bioactive fraction obtained from the plant Woodfordia fruticosa along with one or more pharmaceutically acceptable additives/carriers for treating ulcer caused by the conditions such as stress induced ulcer, peptic ... 10/06/05 - 20050220914 - Pesticide treatments made from hop extracts The invention is an organic pesticide made from components of hop extract by preparing stable aqueous emulsions of hop acids and other hop extract components. The hop acids and other hop extract components are suspended as stable, colloidal preparations in water, which can be sprayed on plants for pest control. ... 09/01/05 - 20050191375 - Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines The invention provides compositions containing a fraction isolated or derived from hops and a methylxanthine. The invention additionally provides compositions containing a fraction derived from hops and a curcuminoid. The invention also provides methods of using such compositions to reduce inflammation. ... 09/01/05 - 20050191374 - Soluble composition containing sporopollenin and the use thereof A composition containing sporopollenin is disclosed which is characterized in that it is present as a solution and, aside from 0.01% to 12% by weight, preferably 0.1% to 5% by weight, of sporopollenin, it also contains 0.01% to 17% by weight, preferably 0.1% to 10% by weight, of at least ... 06/30/05 - 20050142237 - Animal repellent containing extract of clove oil A repellent composition for repelling mice, rats, and other chewing and gnawing animals which deters nesting and habitation in agricultural seeds and agricultural products stored in bulk and in separate containers made from paper, burlap, cotton, plastic, wood and steel. The repellent composition is between 1 to 10% concentration of ... 06/16/05 - 20050129791 - Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 A novel formulation is provided that serves to inhibit the inflammatory response in animals. The formulation comprises, as a first component an effective amount of a curcuminoid species and an effective amount of a second component selected from the group consisting of an alpha-acid species or a beta-acid species or ... 06/02/05 - 20050118294 - Composition for weight reduction comprising water-soluble low-molecular weight chitosan and hibiscus extract The present invention relates to compositions for weight reduction, comprising a water-soluble low-molecular weight chitosan and a Hibiscus extract, and optionally L-carnitine, and methods of using the composition for weight reduction. ... ### FreshPatents.com Support |